Logo image of ABG.DE

CENCORA INC (ABG.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:ABG - US03073E1055 - Common Stock

298.3 EUR
+11.5 (+4.01%)
Last: 1/13/2026, 7:00:00 PM

ABG.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap57.87B
Revenue(TTM)321.33B
Net Income(TTM)1.55B
Shares193.99M
Float185.78M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend1.93
Dividend Yield0.71%
EPS(TTM)13.72
PE21.74
Fwd PE19.53
Earnings (Next)02-04
IPO1996-05-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors
ABG.DE short term performance overview.The bars show the price performance of ABG.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

ABG.DE long term performance overview.The bars show the price performance of ABG.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ABG.DE is 298.3 EUR. In the past month the price decreased by -7.48%.

CENCORA INC / ABG Daily stock chart

ABG.DE Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ABG.DE.


Chartmill TA Rating
Chartmill Setup Rating

ABG.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE. ABG.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABG.DE Financial Highlights

Over the last trailing twelve months ABG.DE reported a non-GAAP Earnings per Share(EPS) of 13.72. The EPS increased by 16.21% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.48%
ROA 2.03%
ROE 103.06%
Debt/Equity 5
Chartmill High Growth Momentum
EPS Q2Q%14.97%
Sales Q2Q%5.92%
EPS 1Y (TTM)16.21%
Revenue 1Y (TTM)9.31%

ABG.DE Forecast & Estimates

22 analysts have analysed ABG.DE and the average price target is 333.83 EUR. This implies a price increase of 11.91% is expected in the next year compared to the current price of 298.3.

For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 6.24% for ABG.DE


Analysts
Analysts80
Price Target333.83 (11.91%)
EPS Next Y11.31%
Revenue Next Year6.24%

ABG.DE Ownership

Ownership
Inst Owners95.74%
Ins Owners0.09%
Short Float %N/A
Short RatioN/A

About ABG.DE

Company Profile

ABG logo image Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Company Info

CENCORA INC

1 West First Avenue

Conshohocken PENNSYLVANIA US

Employees: 44000

ABG Company Website

ABG Investor Relations

Phone: 16107277000

CENCORA INC / ABG.DE FAQ

What does ABG do?

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.


What is the current price of ABG stock?

The current stock price of ABG.DE is 298.3 EUR. The price increased by 4.01% in the last trading session.


Does ABG stock pay dividends?

CENCORA INC (ABG.DE) has a dividend yield of 0.71%. The yearly dividend amount is currently 1.93.


How is the ChartMill rating for CENCORA INC?

ABG.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the market expecting ABG stock to perform?

22 analysts have analysed ABG.DE and the average price target is 333.83 EUR. This implies a price increase of 11.91% is expected in the next year compared to the current price of 298.3.


What is the expected growth for ABG stock?

The Revenue of CENCORA INC (ABG.DE) is expected to grow by 6.24% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Who owns CENCORA INC?

You can find the ownership structure of CENCORA INC (ABG.DE) on the Ownership tab.